Stock Analiz

Medtronic plc (MDT) financials: revenue, earnings and cash flow

Fiscal 2017–2026 + TTM · from SEC filings · data as of November 13, 2026

Summary

Medtronic’s revenue went from $29.7B in fiscal 2017 to $36.4B in fiscal 2026, growth of about 2.3% a year.

Net income in fiscal 2026 was $4.8B, a net margin of 13.2%; the best year in this period was 2022 with $5.0B.

Over the twelve months to July 31, 2026, revenue was $37.5B and net income $5.2B.

Free cash flow was $5.4B in fiscal 2026 and positive in 10 of the 10 years shown.

The diluted share count fell 7% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2017: $29.7B172018: $30.0B182019: $30.6B192020: $28.9B202021: $30.1B212022: $31.7B222023: $31.2B232024: $32.4B242025: $33.5B252026: $36.4B26$36.4B
Net income
2017: $4.0B172018: $3.1B182019: $4.6B192020: $4.8B202021: $3.6B212022: $5.0B222023: $3.8B232024: $3.7B242025: $4.7B252026: $4.8B26$4.8B
Free cash flow
2017: $5.6B172018: $3.6B182019: $5.9B192020: $6.0B202021: $4.9B212022: $6.0B222023: $4.6B232024: $5.2B242025: $5.2B252026: $5.4B26$5.4B
EPS (diluted)
2017: $2.89172018: $2.27182019: $3.41192020: $3.54202021: $2.66212022: $3.73222023: $2.82232024: $2.76242025: $3.61252026: $3.7326$3.73

Income statement

Fiscal yearTTM2026202520242023202220212020201920182017
Revenue$37.5B$36.4B$33.5B$32.4B$31.2B$31.7B$30.1B$28.9B$30.6B$30.0B$29.7B
Gross profit$24.4B$23.6B$21.9B$21.1B$20.5B$21.5B$19.6B$19.5B$21.4B$20.9B$20.4B
Operating income$6.8B$6.5B$6.0B$5.1B$5.5B$5.8B$4.5B$4.8B$6.3B$6.6B$5.4B
Net income$5.2B$4.8B$4.7B$3.7B$3.8B$5.0B$3.6B$4.8B$4.6B$3.1B$4.0B
EPS (diluted)$4.07$3.73$3.61$2.76$2.82$3.73$2.66$3.54$3.41$2.27$2.89
R&D$2.9B$2.9B$2.7B$2.7B$2.7B$2.7B$2.5B$2.3B$2.3B$2.3B$2.2B
Revenue growth—+8.4%+3.6%+3.6%−1.5%+5.2%+4.2%−5.4%+2.0%+0.8%+3.0%

Cash flow

Fiscal yearTTM2026202520242023202220212020201920182017
Operating cash flow$8.0B$7.3B$7.0B$6.8B$6.0B$7.3B$6.2B$7.2B$7.0B$4.7B$6.9B
Capital spending-$1.9B-$1.9B-$1.9B-$1.6B-$1.5B-$1.4B-$1.4B-$1.2B-$1.1B-$1.1B-$1.3B
Free cash flow$6.1B$5.4B$5.2B$5.2B$4.6B$6.0B$4.9B$6.0B$5.9B$3.6B$5.6B
Dividends paid$3.6B$3.6B$3.6B$3.7B$3.6B$3.4B$3.1B$2.9B$2.7B$2.5B$2.4B
Buybacks$1.2B$1.0B$3.2B$2.1B$645M$2.5B$652M$1.3B$2.9B$2.2B$3.5B
Stock-based pay$496M$457M$429M$393M$355M$359M$344M$297M$290M$344M$348M

Balance sheet

Fiscal yearTTM2026202520242023202220212020201920182017
Cash—$9.2B$9.0B$8.0B$8.0B$10.6B$10.8B$10.9B$9.8B$11.2B$13.7B
Debt—$29.3B$29.8B$26.2B$25.6B$25.1B$27.6B$25.9B$26.4B$25.8B$33.4B
Equity—$49.5B$48.0B$50.2B$51.5B$52.6B$51.4B$50.7B$50.1B$50.7B$50.2B
Total assets—$93.0B$91.7B$90.0B$90.9B$91.0B$93.1B$90.7B$89.7B$91.4B$99.9B
Shares (diluted)1.29B1.29B1.29B1.33B1.33B1.35B1.35B1.35B1.36B1.37B1.39B

Margins and returns

Fiscal yearTTM2026202520242023202220212020201920182017
Gross margin65.0%65.0%65.3%65.3%65.7%68.0%65.2%67.4%70.0%69.8%68.7%
Operating margin18.1%17.8%17.8%15.9%17.6%18.1%14.9%16.6%20.5%22.2%18.1%
Net margin13.9%13.2%13.9%11.4%12.0%15.9%12.0%16.6%15.2%10.4%13.6%
FCF margin16.3%14.9%15.5%16.1%14.7%18.9%16.2%20.8%19.2%12.1%18.9%
ROIC—6.5%6.4%5.1%5.0%6.8%5.3%4.9%7.3%4.7%5.6%
ROE—9.7%9.7%7.3%7.3%9.6%7.0%9.4%9.2%6.1%8.0%

Frequently asked questions

What is Medtronic’s annual revenue?

$36.4B in fiscal 2026 and $37.5B over the twelve months to July 31, 2026.

How much profit does Medtronic make?

Net income was $4.8B in fiscal 2026 (net margin 13.2%).

Is Medtronic’s revenue growing?

Yes: revenue rose 8.4% in fiscal 2026 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.